A HIGHLY SENSITIVE POLYCLONAL ANTIBODY-BASED ELISA FOR THERAPEUTIC MONITORING AND PHARMACOKINETIC STUDIES OF LENALIDOMIDE

REFERENCES

• Sonneveld , P. ; Palumbo , A. Lenalidomide: A New Therapy for Multiple Myeloma . EJHPP 2008 , 14 , 58 – 61 .
   Web of Science ®Google Scholar
• Chanan-Khan , A. A. Immunomodulating Drugs for the Treatment of Cancer, , 1st Ed. ; Lippincott Williams : Baltimore , MD , 2011 ; pp. 15 – 27 .
   Google Scholar
• Hugin , R. J. Revlimid® in Combination with Dexamethasone sNDA Granted Approval by FDA for Treatment of Multiple Myeloma . Celgene Corporation: Summit, NJ, 2011. Available at http://ir.celgene.com/phoenix.zhtml?c=111960&p=irol-newsArticle&ID=877894&highlight
   Google Scholar
• Andritsos , L. A. ; Johnson , A. J. ; Lozanski , G. ; Blum , W. ; Kefauver , C. ; Awan , F. ; Smith , L. L. ; Lapalombella , R. ; May , S. E. ; Raymond , C. A. ; Wang , D. ; Knight , R. D. ; Ruppert , A. S. ; Lehman , A. ; Jarjoura , D. ; Chen , C. S. ; Byrd , J. C. Higher Doses of Lenalidomide are Associated with Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients with Chronic Lymphocytic Leukemia . J. Clin. Oncol. 2008 , 26 , 2519 – 2525 .
   PubMed Web of Science ®Google Scholar
• Palumbo , A. ; Falco , P. ; Corradini , P. ; Falcone , A. ; Di Raimondo , F. ; Giuliani , N. ; Ciccone , C. C. G. ; Omedè , P. ; Ambrosini , M. T. ; Gay , F. ; Bringhen , S. ; Musto , P. ; Foà , R. ; Knight , R. ; Zeldis , J. B. ; Boccadoro , M. ; Petrucci , M. T. Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report from the Gimema-Italian Multiple Myeloma Network . J. Clin. Oncol. 2007 , 25 , 4459 – 4465 .
   PubMed Web of Science ®Google Scholar
• Palumbo , A. ; Rajkumar , S. V. ; Dimopoulos , M. A. ; Richardson , P. G. ; San Miguel , J. ; Barlogie , B. ; Harousseau , J. ; Zonder , J. A. ; Cavo , M. ; Zangari , M. ; Attal , M. ; Belch , A. ; Knop , S. ; Joshua , D. ; Sezer , O. ; Ludwig , H. ; Vesole , D. ; Bladé , J. ; Kyle , R. ; Westin , J. ; Weber , D. ; Bringhen , S. ; Niesvizky , R. ; Waage , A. ; von Lilienfeld-Toal , M. ; Lonial , S. ; Morgan , G. J. ; Orlowski , R. Z. ; Shimizu , K. ; Anderson , K. C. ; Boccadoro , M. ; Durie , B. G. ; Sonneveld , P. ; Hussein , M. A. Prevention of Thalidomide- and Lenalidomide-Associated Thrombosis in Myeloma . Leukemia 2008 , 22 , 414 – 423 .
   PubMed Web of Science ®Google Scholar
• Berg , S. L. ; Cairo , M. S. ; Russell , H. ; Ayello , J. ; Ingle , A. M. ; Lau , H. ; Chen , N. ; Adamson , P. C. ; Blaney , S. M. Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children And Adolescents with Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report . J. Clin. Oncol. 2011 , 29 , 316 – 323 .
   PubMed Web of Science ®Google Scholar
• Giagounidis , A. ; Fenaux , P. ; Mufti , J. G. ; Muus , P. ; Platzbecker , U. ; Sanz , G. ; Cripe , L. ; Von Lilienfeld-Toal , M. ; Wells , R. A. Practical Recommendations on the Use of Lenalidomide in the Management of Myelodysplastic Syndromes . Ann. Hematol. 2008 , 87 , 345 – 352 .
   PubMed Web of Science ®Google Scholar
• Hussein , M. A. Lenalidomide: Patient Management Strategies . Seminars Hematol. 2005 , 42 , S22 – S25 .
   PubMed Web of Science ®Google Scholar
• Tohnyaa , T. M. ; Hwanga , K. ; Leppera , E. R. ; Fineb , H. A. ; Dahutc , W. L. ; Venitzd , J. ; Sparrebooma , A. ; Figga , W. D. Determination of CC-5013, an Analogue of Thalidomide, in Human Plasma by Liquid Chromatography–Mass Spectrometry . J. Chromatogr. B 2004 , 811 , 135 – 141 .
   PubMed Web of Science ®Google Scholar
• Qing , L. ; Katherine , F. ; Amy , J. ; Natarajan , M. ; Craig , H. ; Kristie , B. ; Larry , S. ; Michael , G. ; John , B. ; James , D. ; Mitch , P. Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human Plasma . Ther. Drug Monit. 2008 , 30 , 620 – 627 .
   PubMed Web of Science ®Google Scholar
• Darwish , I. A. Immunoassay Methods and Their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances . Int. J. Biomed. Sci. 2006 , 2 , 217 – 235 .
   PubMedGoogle Scholar
• Darwish , I. A. ; Alzoman , N. Z. ; Abuhejail , R. M. ; El-Samani , T. E. Synthesis of Hapten and Preparation of Specific Polyclonal Antibody with High Affinity for Lenalidomide, the Potent Drug for Treatment of Multiple Myeloma . Chem. Cent. J. 2012 , 125 , p. 8 .
   Google Scholar
• Darwish , I. A. ; Mahmoud , A. M. ; Aboul-Fadl , T. ; Al-Majed , A. A. ; Khalil , N. Y. A Highly Sensitive Enzyme Immunoassay for Evaluation of 2′-deoxycytidine Plasma Level as a Prognostic Marker for Breast Cancer Chemotherapy . Anal. Chim. Acta 2009 , 632 , 266 – 271 .
   PubMed Web of Science ®Google Scholar
• Findlay , J. W. ; Smith , W. C. ; Lee , J. W. ; Nordblom , G. D. ; Das , I. ; De Silva , B. ; SKhan , M. N. ; Bowsher , R. R. Validation of Immunoassays for Bioanalysis: A Pharmaceutical Industry Perspective . J. Pharm. Biomed. Anal. 2000 , 21 , 1249 – 1273 .
   PubMed Web of Science ®Google Scholar